Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company focused on helping patients who suffer from severe respiratory diseases to breath better and live life more fully. The company is being purpose-built using our proprietary nitric oxide platform technology. These preclinical assets are licensed from Novan (NASDAQ:NOVN) and were developed in collaboration with Dr. Mark Schoenfisch’s lab at UNC Chapel ...
Vast Therapeutics is an innovative, preclinical-stage pharmaceutical company focused on helping patients who suffer from severe respiratory diseases to breath better and live life more fully. The company is being purpose-built using our proprietary nitric oxide platform technology. These preclinical assets are licensed from Novan (NASDAQ:NOVN) and were developed in collaboration with Dr. Mark Schoenfisch’s lab at UNC Chapel Hill.

List your booth number for exhibitions, ask us